Kenvue stock gained 1.15 percent as merger plans advance
Published on 10/07/2026 at 03:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Kenvue stock (ISIN US49177J1025) was last at USD 17.59 on the NYSE on October 6, 2026 at 4:00 p.m. ET, up 1.15 percent from the prior close. The move came as Kimberly-Clark advanced preparations for its planned acquisition of the consumer health company.
Merger planning moves forward
According to Kimberly-Clark on October 1, 2026, the transaction remains on track to close in the fourth quarter of 2026, subject to regulatory approvals and customary closing conditions. The release also assigned future leadership roles to Kenvue executives Carlos De Jesus and Leonardo Curado after completion.
The integration plan gives the deal a more concrete operating structure. De Jesus is set to lead the combined North American segment, while Curado is scheduled to lead Europe, the Middle East and Africa from January 1, 2027.
Revenue growth sets the baseline
Kenvue reported second-quarter 2026 revenue of USD 3.955 billion on August 6, 2026, an increase of 3.0 percent from the same quarter a year earlier. Diluted EPS was USD 0.24, while adjusted diluted EPS reached USD 0.31, up 7 percent year over year.
The operating picture is mixed in a precise way: revenue growth is visible, but the reported quarter still produced a diluted EPS result below the adjusted measure. That distinction matters because merger value depends not only on brand scale, but also on the conversion of sales into cash earnings.
Analysts see measured upside
According to MarketBeat on October 6, 2026, 12 research firms carried a Hold consensus, with 10 Hold ratings and two Buy ratings. The average one-year price target was USD 19.00, which places the target 8.0 percent above the October 6 price of USD 17.59.
MarketBeat also reported that Barclays raised its target from USD 18.00 to USD 19.00 on July 21, 2026, while UBS cut its target from USD 20.00 to USD 19.00 on August 11, 2026. The spread between those actions leaves deal execution and regulatory clearance as the central variables for the stock.
Kenvue stock stays below yearly high
Kenvue stock traded within a 52-week range of USD 14.02 to USD 20.13 on October 6, 2026. Its USD 17.59 price was 12.6 percent below the yearly high, while market capitalization stood at USD 33.8 billion and volume reached 10,870,668 shares.
Kenvue stock facts
- Company: Kenvue Inc.
- ISIN: US49177J1025
- Ticker: KVUE
- Trading venue: NYSE
- Price (as of October 6, 2026, 4:00 p.m. ET): USD 17.59
- Market capitalization: USD 33.8 billion (as of October 6, 2026)
- 52-week range: USD 14.02-20.13 (as of October 6, 2026)
- Sector / Industry: Consumer Defensive / Household and Personal Products
- Next earnings date: November 11, 2026
More news and analyses on Kenvue stock are available on the Kenvue stock topic page.
